Geoffrey Teixeira

SVP & Head Fibrosis at Alentis Therapeutics

Geoffrey Teixeira joined Alentis as Head of Fibrosis in Sept 2021, bringing more than 9 years of industrial drug development experience in inflammatory and fibrotic diseases. He was most recently Translational Research Lead of Fibrosis at Galapagos, Mechelen, Belgium. In this role, he was responsible for leading translational activities for the company’s fibrosis pipeline, and for reverse translation activities and platform development, combining multi-omics and machine learning approaches for the identification of new targets and biomarkers.

Prior to Galapagos, Geoffrey was Project Leader and Therapeutic Area Lead of Fibrosis at Evotec, Göttingen, Germany, overseeing and bringing drug discovery programs (small molecules and biologics) as well as the R&D platforms of NASH and tissue fibrosis to decision milestones. These initiatives led to multiple alliances with biopharmaceutical companies and investors. He also worked as a scientist at Genkyotex, Geneva, Switzerland where he was responsible for setting-up animal models for tissue fibrosis.

Geoffrey holds a PhD in Physiology from the University of Lyon, France.

Links

Previous companies

Evotec logo
Galapagos logo

Org chart